These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19064405)

  • 1. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
    [No Abstract]   [Full Text] [Related]  

  • 2. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continuum of care: a paradigm for the management of metastatic colorectal cancer.
    Goldberg RM; Rothenberg ML; Van Cutsem E; Benson AB; Blanke CD; Diasio RB; Grothey A; Lenz HJ; Meropol NJ; Ramanathan RK; Becerra CH; Wickham R; Armstrong D; Viele C
    Oncologist; 2007 Jan; 12(1):38-50. PubMed ID: 17227899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
    Marshall JL
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conversion therapy for colorectal cancer].
    Sasaki N; Yoshino T
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1793-7. PubMed ID: 22164897
    [No Abstract]   [Full Text] [Related]  

  • 6. How to integrate biologicals in the continuum of care.
    Venugopal B; Cassidy J
    Eur J Cancer; 2009 Sep; 45 Suppl 1():57-69. PubMed ID: 19775605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in colorectal carcinoma].
    Schmiegel W; Petrasch S
    Internist (Berl); 1994 Dec; 35(12):1086-94. PubMed ID: 7533749
    [No Abstract]   [Full Text] [Related]  

  • 8. Individualizing therapy for metastatic colorectal cancer.
    Turja J; Grothey A
    Oncology (Williston Park); 2008 Nov; 22(13):1479-81. PubMed ID: 19227569
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects and medication therapy strategies for out-patient uro-oncological therapy].
    Rinnab L; Küfer R
    Urologe A; 2009 Nov; 48(11):1261-2. PubMed ID: 19844671
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal approach to potentially resectable liver metastases from colorectal cancer.
    Falcone A; Fornaro L; Loupakis F; Masi G; Vasile E
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1533-9. PubMed ID: 18925845
    [No Abstract]   [Full Text] [Related]  

  • 12. [The SOR program of guidelines for clinical practice. Palliative chemotherapy as first line treatment of metastatic colorectal cancer, 2003 update].
    Gastroenterol Clin Biol; 2004 Jun; 28(6-7 Pt 2):E1-71. PubMed ID: 15286580
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic strategies for colorectal cancer in Europe and the United States: focus on chemotherapy for advanced colorectal cancer.
    Bennouna J; Douillard JY
    Int J Clin Oncol; 2002 Aug; 7(4):236-44. PubMed ID: 12202977
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the treatment of metastatic colorectal cancer in Taiwan.
    Lin YL; Yeh KH; Cheng AL
    J Formos Med Assoc; 2011 Jan; 110(1):1-3. PubMed ID: 21316006
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular markers of chemotherapy in advanced colorectal cancer: back to square one.
    Sobrero A
    Eur J Cancer; 2009 Jul; 45(11):1902-3. PubMed ID: 19502051
    [No Abstract]   [Full Text] [Related]  

  • 16. [The chemotherapy of advanced colorectal carcinoma in the elderly patient. The new oral fluoropyrimidines].
    Di Costanzo F; Sdrobolini A; Gasperoni S; Basirat F
    Minerva Med; 1999; 90(7-8):234-41. PubMed ID: 10719427
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A; Lurje G; Manegold PC; Lenz HJ
    Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
    Kruzelock RP; Short W
    Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.
    Jiang Y; Kimchi ET; Staveley-O'Carroll KF; Cheng H; Ajani JA
    Cancer; 2009 Aug; 115(16):3609-17. PubMed ID: 19526592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.